$Moderna, Inc.(MRNA)$Moderna and Merck’s personalized cancer therapy met its key goals in a Phase 3 melanoma trial, sending MRNA sharply higher and lifting the broader biotech sector. Biotech stocks have finally found a major catalyst. Moderna (MRNA) surged roughly 177%, while Merck (MRK) gained about 12.6%. BioNTech (BNTX), which is also developing mRNA-based cancer treatments, climbed nearly 22%. Biotech ETFs XBI and IBB rose about 5.9% and 6.6%, respectively. The catalyst was positive Phase 3 data for intismeran autogene, also known as V940 or mRNA-4157. The personalized mRNA therapy is being jointly developed by Moderna and Merck and tested in combination with Merck’s blockbuster immunotherapy drug Keytruda. The combination met

The Philadelphia Semiconductor Index fell 5% on Tuesday, with memory, storage and optical-networking stocks leading the decline. There was no clear deterioration in industry fundamentals. Rising Treasury yields, higher oil prices and profit-taking in crowded AI trades combined to trigger a sharp valuation reset. 1. Semiconductor Sentiment Reversed in One Session On Monday, AI storage was one of the strongest areas of the market: SanDisk gained 8.9% Micron rose 4.1% Western Digital, Seagate and optical-networking stocks also advanced One day later, the trade reversed sharply. Stock Tuesday Segment SNDK −9.0% NAND and enterprise SSDs WDC −7.4% Data-center HDDs MU −7.0% DRAM and HBM AMD −4.3% AI processors AVGO −3.2% Custom chips and networking NVDA −2.3% AI GPUs COHR −12.8% Optical networkin

Wall Street has just given the bulls another reason to celebrate. J.P. Morgan raised its 2026 year-end target for the S&P 500 from 7,800 to 8,000. Based on Friday’s close of 7,757.64, however, that leaves only about 3.1% of upside. At least seven Wall Street brokerages now expect the index to reach the 8,000 level by year-end. Reuters The headline sounds extremely bullish. But the more important question is not whether the S&P 500 can gain another 3%. It is why J.P. Morgan became more confident after the index had already reached a record high. This Rally Is Finally Getting More Earnings Support Of the 436 S&P 500 companies that had reported second-quarter results through Friday morning, 85.1% beat analyst expectations. That is well above the long-term average of 68%. J.P. Morg

SpaceX Rallies 6% After Its Lockup Expiration: Is the Next Opportunity in Space Stocks? SpaceX has finally given the public space sector something it has long lacked: a genuine valuation anchor. On August 6, approximately 911.5 million SpaceX shares became eligible for trading. Investors feared that employees and early shareholders would rush to sell, yet after plunging nearly 14% the previous day, $SpaceX(SPCX)$ rebounded 6.1% to close at $114.92. This does not mean the selling pressure is over. By December 8, tradable shares could rise to roughly 40% of SpaceX’s total shares outstanding, leaving the stock exposed to further supply and volatility. Reuters But the more interesting signal came from the rest of the sector.

Apple wanted to add a new DRAM supplier to lower costs. Instead, the potential supplier reportedly refused to offer a cheaper price. On August 5, South Korea’s Digital Daily reported that Apple had recently held procurement talks with Chinese memory-chip maker CXMT over LPDDR5X mobile DRAM. Apple reportedly asked for a further price reduction, but CXMT refused. Its quotes were said to be close to those of Samsung and SK Hynix—and, for some products, even higher. (Digital Daily) Neither Apple nor CXMT has publicly confirmed the talks, and no specific pricing details have been disclosed. Still, the report is not an isolated signal. Reuters reported in July that CXMT had started raising prices for major customers including Huawei, with some DDR5 server-memory products quoted above comparable

Wall Street has quickly moved from correction fears back to record-high excitement. On Monday, the Dow gained 1.32% to close at a record 53,178. The S&P 500 rose 1.48% to 7,600, while the Nasdaq climbed 2.13%. Falling oil prices and lower Treasury yields gave growth stocks another boost, while strong earnings brought capital back into technology and AI names. That leaves investors facing an uncomfortable question: Are earnings pulling the market higher, or is fear of missing out creating a high-valuation melt-up? Tonight may provide an important answer. $Advanced Micro Devices(AMD)$ and $Arista Networks(ANET)$ both report after the closing bell. AMD represents the computing layer of the AI buildout. Ar

After several brutal sessions, global technology stocks finally staged a powerful rebound. The Nasdaq rose 2.8%, while Microsoft’s post-earnings surge helped lift AI chips, cloud stocks and data-center names across the board. The move became even more dramatic in Asia. South Korea’s KOSPI jumped sharply, with Samsung Electronics and SK hynix surging as investors rushed back into semiconductor names. Taiwan’s market also rebounded strongly, led by TSMC. At first glance, this looks like a classic V-shaped reversal. But the more important question is: Has the correction really ended, or is the market only beginning a longer U-shaped repair process? Why did the rebound happen so quickly? The first reason is earnings. Microsoft showed that AI spending can already translate into cloud revenue, p